Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
09/2010
09/08/2010CN101376878B Pig propagation and breathing syndrome virus stain, and inactivated vaccine prepared thereby
09/08/2010CN101362758B Penem derivates containing sulfhydryl pyrrolidine vinyl heterocycle
09/08/2010CN101328479B Chrysalid pteromalid antibiotic protein Pp-AP5 and encoding nucleic acid sequence thereof
09/08/2010CN101311189B Antigen epitope for exciting protective immunity against tubercle bacillus of human body and uses thereof
09/08/2010CN101269202B Method for preparing Chinese medicine for treating stasis type acute simplex appendicitis
09/08/2010CN101254229B Medicament preventing and treating viral infection of upper respiratory tract and method of preparing the same
09/08/2010CN101249204B Pulmonary tuberculosis treating Chinese medicine
09/08/2010CN101249105B Tuberculosis resistance Chinese medicine and method of preparing the same
09/08/2010CN101239072B Medicaments for treating syphilis disease and preparation thereof
09/08/2010CN101224281B Chinese traditional medicine preparation for purulent inflammation of skin
09/08/2010CN101181444B Multi-efficacy externally used drug as well as method for preparing immersion agent thereof
09/08/2010CN101180051B Method for preparation of aqueous doripenem solution
09/08/2010CN101167859B Medicinal preparation for preventing and treating hog cholera and fowl plague
09/08/2010CN101167855B Medicine for treating tinea pedis and tinea manuum
09/08/2010CN101152195B Application of aminoglycoside antibiotic in preparing pharmaceutical composition for treating drug-fast bacteria infection
09/08/2010CN101143870B Novel cephalosporin derivative
09/08/2010CN101119971B Cyclohepta[b]pyridine-3-carbonylguanidine derivative and pharmaceutical product containing same
09/08/2010CN101099735B Wide-spectrum high-efficient microorganism killing agent
09/08/2010CN101070342B Balsm-pear-seed ribosome inactivated protein and its coding gene and use
09/08/2010CN101066403B New process of preparing fresh snow preparation
09/08/2010CN101036720B External Chinese traditional medicine compound for curing tineamanuum
09/08/2010CN101036695B Oil-in-water type nanometer emulsion of elecampane oil and litsea citrata oil and the method for preparing the same
09/08/2010CN101028358B Oral Chinese medicinal composition for treating ribbon bleb
09/08/2010CN101024013B Medicine for treating tuberculosis
09/08/2010CN101015573B Patrinai villosa dropping pill and its preparing process
09/07/2010US7790916 therapy of NF-kappaB mediated diseases; mitochondrial diseases; transplantation medicine
09/07/2010US7790870 nucleic acid molecule encoding a fusion protein comprising four linked polypeptides; suitable for use in gene therapeutical treatment of patients infected with HIV
09/07/2010US7790851 heterodimeric receptor complex comprising an isolated soluble cytokine receptor and a soluble zcytor11 polypeptide; for use in treatment of cell proliferative, inflammatory and immune disorders
09/07/2010US7790771 Chloramine-t as a wound healing agent and viricide, particularly the herpes and varicella viruses; pruritus; skin disorders; diseasesof the mucous membranes, organs and tissues; with the exception of treatment of retro-viral (HIV) diseases; dermatitis; acne; psoriasis; side effect reduction
09/07/2010US7790749 Antiulcer agents; gastrointestinal disorders; anticancer agents; anemia
09/07/2010US7790748 N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones
09/07/2010US7790740 administering chemokine receptor antagonist such as N-{(1S)-3-[3-endo-(5-Acetyl-2-methyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-1-yl)-8-azabicyclo[3.2.1]oct-8-yl]-1-(-3-fluorophenyl)propyl}acetamide, for the treatment of viral, bacterial and protozoa infections
09/07/2010US7790738 Methods of treating and preventing AIDS using of COX-2 inhibitors
09/07/2010US7790736 Dipeptidyl peptidase inhibitors
09/07/2010US7790730 1-((3-(4-chlorophenyl)isoxazol-5-yl)methyl)-8-(2,3-difluorophenyl)-1H-purine, used treat or prevent viral infections such as hepatitis C virus (HCV)
09/07/2010US7790723 1-[3-(3-cyclopentyloxy-4-methoxyphenyl)-3,4,5,6-tetrahydropyridazin-1-yl]-1-[4-methyl-2-(1-oxypyridin-2-yl)thiazol-5-yl]methanone, used for inhibiting proliferation of lymphocytes in a host, and for the treatment of osteoporosis, tumors, cachexia, atherosclerosis, arthritis, multiple sclerosis, diabetes
09/07/2010US7790716 fatty acid biosynthesis inhibitors such as E)-3-(6-aminopyridin-3-yl)-N-methyl-N-(1-methyl-1H-pyrrolo[2,3-b]pyridin-3-ylmethyl)acrylamide, used fro the treatment of bacterial infections; antibiotics
09/07/2010US7790713 Inhibitors of interleukin-1β converting enzyme
09/07/2010US7790709 Heterocyclic compounds, methods of making them and their use in therapy
09/07/2010US7790703 New phosphonate ester derivatives of purine or pyrimidine antivirals; side effect reduction, less toxic, bioavailability
09/07/2010US7790696 Cationic liposomes containing immune response generating moieties
09/07/2010US7790449 Adeno-associated virus (AAV) serotype 8 sequences, vectors containing the same, and uses therefor
09/07/2010US7790419 Antiviral vectors
09/07/2010US7790180 Attenuated rotavirus population comprising a single variant or substantially a single variant which is defined by a nucleotide sequence encoding at least one of the major viral proteins designated as VP4 and VP7; diarrhea therapy
09/07/2010US7790179 Attenuated rotavirus population comprising a single variant or substantially a single variant which is defined by a nucleotide sequence encoding at least one of the major viral proteins designated as VP4 and VP7; diarrhea therapy
09/07/2010US7790178 vaccine for canine herpesvirus (CHV), canine rotavirus (CRV), and Minute virus of canine (MVC) or other canine parvovirus delivered to pups of a whelp through colostrums and providing sufficient antibody titer to impart protection
09/07/2010US7790171 Vircidal agent for treatment of multidrug-resistant human immunodeficiency viral infections
09/07/2010US7790168 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
09/07/2010US7790158 Using tumor necrosis factors specific immunoglobulins to treat rheumatoid arthritis, diabetes type I, multiple sclerosis, and inflammatory bowel diseases
09/07/2010CA2608864C Recombinant mva virus, and the use thereof
09/07/2010CA2596274C Recombinant mva virus, and the use thereof
09/07/2010CA2531825C Adjuvant combinations of liposomes and mycobacterial lipids for immunization compositions and vaccines
09/07/2010CA2493680C Condensed heterocyclic pyrazole derivatives as kinase inhibitors
09/07/2010CA2453112C New cationic peptides of the dermaseptin family isolated from the skin secretion of phyllomedusa hypochondrialls
09/07/2010CA2431188C Pharmaceutical compositions enhancing the immunogenicity of poorly immunogenic antigens
09/07/2010CA2406229C Anti-sepsis conjugate vaccine
09/07/2010CA2338172C Novel 6-deoxy erythromycin derivatives, method for preparing same and use as medicines
09/07/2010CA2334615C Production process for polymeric micelle charged therein with drug and polymeric micelle composition
09/03/2010CA2695093A1 Method for diagnosing staphylococcal infections
09/02/2010WO2010099536A2 Engineered proteins with high affinity for dota chelates
09/02/2010WO2010099458A1 Combination of a nucleoside polymerase inhibitor with a macrocyclic protease inhibitor and use thereof in the treatment of hepatitis c, liver fibrosis and impaired liver function
09/02/2010WO2010099169A2 A novel in vitro hiv-1 latency model for screening reactivation agents of hiv-1
09/02/2010WO2010099159A1 Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors
09/02/2010WO2010098843A2 Peptoid oligomers, pharmaceutical compositions and methods of using the same
09/02/2010WO2010098429A1 Immunologic adjuvant composition and use thereof
09/02/2010WO2010098365A1 Nucleoside-type antibiotic
09/02/2010WO2010097816A1 Flavanoid compounds and process for preparation thereof
09/02/2010WO2010097626A2 Compounds and methods relating thereto
09/02/2010WO2010097229A2 Amorphous salt of a macrocyclic inhibitor of hcv
09/02/2010WO2010096987A1 Use of patchouli alcohol in medicament preparation
09/02/2010WO2010096888A1 Vaccines containing attenuated strains, method for forming attenuated strains, vaccine vectors and use thereof for the treatment of salmonellosis
09/02/2010WO2010096853A1 Methods of modulating the activity of the mc1 receptor and treatment of conditions related to this receptor
09/02/2010WO2009158118A3 Anti-bacterial agents from benzo[d]heterocyclic scaffolds for prevention and treatment of multidrug resistant bacteria
09/02/2010WO2009115893A3 Novel 2 ', 2 ', 3 ', 3 ' -tetrasubstiuted nucleoside derivatives
09/02/2010US20100222591 New Compounds
09/02/2010US20100222426 Anti-Bacterial Agents
09/02/2010US20100222410 Nuclease compositions and methods
09/02/2010US20100222403 Micogel Topical Formulations
09/02/2010US20100222400 F1F0-ATPase Inhibitors and Related Methods
09/02/2010US20100222391 Benzimidazole compound crystal
09/02/2010US20100222384 Iminosugars and methods of treating arenaviral infections
09/02/2010US20100222383 Iminosugars and methods of treating viral diseases
09/02/2010US20100222368 N-(Heteroaryl)-1-heteroarylalkyl-1H-indole-2-carboxamide derivatives, preparation and therapeutic use thereof
09/02/2010US20100222366 Piperidine derivatives as modulators of chemokine receptor activity
09/02/2010US20100222363 Bicyclic Derivatives as P38 Inhibitors
09/02/2010US20100222352 Compounds and Methods for the Treatment of Viruses and Cancer
09/02/2010US20100222348 Quinolinone derivatives as parp inhibitors
09/02/2010US20100222332 Pyrazolo-pyrazines derivatives used as g protein inhibitors
09/02/2010US20100222331 New compounds
09/02/2010US20100222322 Non-Nucleoside Reverse Transcriptase Inhibitors
09/02/2010US20100222308 Ophthalmic, otic or nasal pharmaceutical composition and the use thereof
09/02/2010US20100222302 Novel Antibacterial Compounds
09/02/2010US20100222298 Spill resistant formulations containing clays
09/02/2010US20100222295 Anti-Viral Pyrimidine Nucleoside Derivatives
09/02/2010US20100222289 Methods for diagnosis and treatment of chronic fatigue syndrome
09/02/2010US20100222286 Receptor modulators exhibiting neuroprotective and memory enhancing activities
09/02/2010US20100222272 Pharmaceutical Compositions for the Treatment of TNF-Alpha Related Disorders
09/02/2010US20100222268 Antibiotic peptides
09/02/2010US20100222266 Cytokine receptor protein for use in identifying modulators which prevent hepatitis viral replication and infection; viricides
09/02/2010US20100222258 TNF antagonist and TNF inhibitor containing it as an effective ingredient
1 ... 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 ... 1798